Three Icons of Stage and Screen Lost to Ovarian Cancer
Judy Tenuta, Gilda Radner, and Cassandra Harris were wonderful comedians and actresses who brought joy to millions of people.
The Way Forward Is Clearer, Together.
Each year, WCRF designs, funds, conducts, and publishes numerous clinical studies on the spectrum of women’s cancers. All our gynecologic oncology experts work with the belief that each new clinical trial carries the potential to fundamentally change the future of patients with women’s cancers.
Take a look at how WCRF has contributed to the field of gynecologic oncology.
Search
-
- Oct 11
- 1 min
New Treatment Brings Remission of Rectal Cancer in All Patients
A small study delivers startling results on the power of a new immunotherapy treatment against rectal cancer...
-
- Oct 5
- 1 min
Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older
In a recent study, researchers sought to assess the association between use of bisphosphonates and the risk of epithelial ovarian cancer.
-
- Sep 20
- 1 min
Physical Activity and Gynecologic Cancer Outcomes
Physical activity is associated with improved cancer outcomes, but it is unclear which patients may benefit most from increased.....
-
- Aug 31
- 1 min
‘Drug factory’ Implants Eliminate Ovarian, Colorectal Cancer in Mice
Rice University bioengineers have shown they can eradicate advanced-stage ovarian and colorectal cancer in mice in as little as six days.
-
- Aug 23
- 1 min
Genetic Testing — A Game-Changer
Since 2003, when scientists successfully mapped the human genome, personalized cancer therapy has transformed cancer treatment.
-
- Aug 1
- 1 min
Malnutrition As A Risk Factor for Post-operative Morbidity in Gynecologic Cancer
An article from Gynecologic Oncology reviewed the association between various malnutrition definitions with post-operative morbidity.
-
- Jul 26
- 2 min
Prevention of Ovarian Cancer
Risk reduction for women who carry BRCA1/2 mutations can achieve a 95% reduced risk of ovarian cancer through a risk-reducing...
-
- Jul 20
- 1 min
Liquid Biopsy in Ovarian Cancer
In recent years there have been considerable efforts to develop a blood test or liquid biopsy...
-
- Jul 11
- 2 min
Risk of Peritoneal Cancer After Risk-Reducing Bilateral Salpingo-Oophorectomy for Women
The average lifetime risk of developing ovarian cancer risk for women who harbor a BRCA1 or BRCA2 pathogenic germline mutation is 44% & 17%
-
- Jul 6
- 2 min
Breast Cancer Surgery Choice May Affect Young Survivors’ Quality of Life
Women diagnosed with breast cancer who had one or both breasts surgically removed had lower scores on a quality-of-life survey.
-
- Jun 28
- 2 min
Daily Aspirin Offers No Benefit in Breast Cancer Survivors
A recent study reported that daily intake of aspirin does not appear to prevent a recurrence of invasive breast cancer.
-
- Jun 24
- 2 min
Impact of Care by Gynecologic Oncologists on Primary Ovarian Cancer Survival: Population-based Study
Prompt treatment of advanced-stage ovarian cancer by a gynecologic oncologist with a combination of surgery and chemotherapy is approved...
-
- Jun 15
- 2 min
Contraceptive Use and the Risk of Ovarian Cancer Among Women With a BRCA1 or BRCA2 Mutation
Women with a BRCA1 and BRCA2 mutation have a higher lifetime risk of developing ovarian cancer.
-
- May 20
- 1 min
Ovarian Cancer Incidence and Death in Women Undergoing Bilateral Salpingo-Oophorectomy
Magnitude of risk reduction obtained with bilateral salpingo-oophorectomy remains unclear and must be weighed against the potential risks of
-
- May 18
- 2 min
A 2022 Physician's Guide to Hopes and Challenges of Cervical Cancer Eradication
Each year more than 14,000 women in the United States will be diagnosed with cervical cancer and more than 4,000 people will die from it.
-
- May 16
- 2 min
When Ovarian Cancer Returns, Surgery May Be a Good Choice for Selected Patients
A recent clinical trial revealed that a secondary surgery followed by chemotherapy can improve survival compared to chemotherapy alone.
-
- Apr 25
- 2 min
New Drug Combination Shown to be Effective for Patients with Advanced Ovarian Cancer
Ovarian cancer is the most lethal gynecologic malignancy. Novel approaches for relapsed ovarian cancer are necessary to improve survival.
-
- Apr 22
- 2 min
Clinical Characteristics, Pregnancy Outcomes & Ovarian Function - A Retrospective Age-Matched Study
Researchers evaluated the prognosis and pregnancy outcomes of pregnancy-associated breast cancer, a rare disease with increasing incidence.
-
- Apr 19
- 1 min
Lighting the Way for Improved Detection of Ovarian Cancer
Pafolacianine, an imaging drug that can help surgeons identify ovarian cancer lesions, has recently been accorded FDA approval.